Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-22
DOI
10.1038/s41598-018-34193-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
- (2018) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
- (2018) Michael Seiler et al. NATURE MEDICINE
- Increased Plasmodium falciparum Parasitemia in Non-splenectomized Saimiri sciureus Monkeys Treated with Clodronate Liposomes
- (2017) Janaiara A. Cunha et al. Frontiers in Cellular and Infection Microbiology
- The role of monocyte subpopulations in vascular injury following partial and transient depletion
- (2017) Etty Grad et al. Drug Delivery and Translational Research
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Reprogramming cancer cells: A novel approach for cancer therapy or a tool for disease-modeling?
- (2015) Açelya Yilmazer et al. CANCER LETTERS
- Modeling of hematologic malignancies by iPS technology
- (2015) Shunya Arai et al. EXPERIMENTAL HEMATOLOGY
- Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
- (2015) Andriana G Kotini et al. NATURE BIOTECHNOLOGY
- JMML patient-derived iPSCs induce new hypotheses
- (2013) R. J. Chan et al. BLOOD
- GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
- (2013) E. Padron et al. BLOOD
- Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
- (2013) S. Gandre-Babbe et al. BLOOD
- Differentially methylated regions in maternal and paternal uniparental disomy for chromosome 7
- (2013) Katariina Hannula-Jouppi et al. Epigenetics
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- Generation of Engraftable Hematopoietic Stem Cells From Induced Pluripotent Stem Cells by Way of Teratoma Formation
- (2013) Nao Suzuki et al. MOLECULAR THERAPY
- In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells
- (2012) G. Amabile et al. BLOOD
- Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice
- (2012) David A. Ferenbach et al. KIDNEY INTERNATIONAL
- An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells
- (2012) Keisuke Okita et al. STEM CELLS
- Butyrate Greatly Enhances Derivation of Human Induced Pluripotent Stem Cells by Promoting Epigenetic Remodeling and the Expression of Pluripotency-Associated Genes
- (2010) Prashant Mali et al. STEM CELLS
- Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells
- (2009) Yoshinori Yoshida et al. Cell Stem Cell
- Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming
- (2009) Jie Deng et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now